Cargando…
Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model
Alzheimer’s disease (AD) is characterized by the presence of tau protein inclusions and amyloid beta (Aβ) plaques in the brain, with Aβ peptides generated by cleavage of the amyloid precursor protein (APP) by BACE1 and γ-secretase. We previously described a primary rat neuron assay in which tau incl...
Autores principales: | Gibbons, Garrett S., Gould, Hailey, Lee, Virginia M.-Y., Crowe, Alex, Brunden, Kurt R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331484/ https://www.ncbi.nlm.nih.gov/pubmed/37269953 http://dx.doi.org/10.1016/j.jbc.2023.104876 |
Ejemplares similares
-
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
por: Gibbons, Garrett S., et al.
Publicado: (2020) -
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019) -
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
por: Gibbons, Garrett S., et al.
Publicado: (2019) -
In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
por: Xu, Hong, et al.
Publicado: (2021) -
Modulating disease-relevant tau oligomeric strains by small molecules
por: Lo Cascio, Filippa, et al.
Publicado: (2020)